Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Automated Vial Capper Machine and Labeler system

Closed
CBER-2026-133944Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The U.S. Food and Drug Administration’s Office of Acquisition and Grant Services is seeking market information for an Automated Vial Capper Machine and Labeler System to be deployed at the Federal Research Center in Silver Spring, Maryland. This sources sought notice, identified as CBER-2026-133944, is not a solicitation but a market research tool aimed at determining the availability of small business manufacturers capable of supplying U.S.-made equipment that meets strict technical and regulatory requirements. The system must handle 3 mL and 5 mL vials with 13 mm and 20 mm aluminum crimp caps at a minimum throughput of 60 vials per minute, fit within a 16 x 5 feet footprint, and feature a 4.3-inch color touchscreen HMI with variable speed control, consistent capping torque, and precise labeling placement. Equipment must operate on standard 115-volt, 60 Hz, single-phase power with clean compressed air at 30 psi or as specified, and include installation, onsite qualification, and training with no separate shipping charges. The machine must support Factory Acceptance Testing, and the contractor must submit Installation and Operational Qualification protocols for FDA approval prior to execution, followed by Performance Qualification using actual production materials. Responses must demonstrate, not merely assert, technical capability through detailed documentation including ISO certifications, technical specifications, product brochures, and three years of past performance providing similar systems. Respondents must identify their business size status under U.S. socioeconomic programs such as Small Business, Veteran-Owned, or Woman-Owned, and include their SAM Unique Entity ID. If the product is sourced from a different manufacturer, that entity’s information must also be provided. The system must comply with Section 508 accessibility standards and include an Accessibility Conformance Report based on the Voluntary Product Accessibility Template Version 2.0, and must adhere to Buy American and Made in America requirements with full disclosure of manufacturing origin. Contractors must comply with stringent FDA facility access protocols, including Real ID or U.S. government-issued passport authentication, White Oak campus parking access, mandatory escorting by FDA staff at all times, and strict adherence to security procedures at designated entry points. Delivery must be coordinated 48 hours in advance and occur between 9 AM and 3 PM on the FDA campus, with full installation and validation completed within 90 days of award and an anticipated 12-month warranty period beginning September 2026. The government

General Info

FDA seeks vendors for automated vial capper and labeler; responses due June 11, 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

333993 - Packaging Machinery ManufacturingView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

(1)

Sources Sought for Automated Vial Capper and Labeler System - FDA CBER

DOCXsources-sought

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA

Full Description

Show more

See attached sources sought notice.



More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS